COVID-19 from bench to bedside / edited by Debmalya Barh, Kenneth Lundstrom.

Other author Barh, Debmalya.
Other author Lundstrom, Kenneth H.
Format Electronic
EditionFirst edition.
Publication InfoBoca Raton, FL : CRC Press, 2022.
Descriptionpages cm
Supplemental ContentFull text available from Taylor & Francis eBooks
Subjects
COVID-19--drug therapy.
COVID-19--diagnosis.
COVID-19--prevention & control.
Pandemics
COVID-19 Vaccines--therapeutic use.

Uniform titleCOVID-19 (Barh)
Contents Coronavirus epidemics and the current COVID-19 pandemic / Aparna Bhardwaj, Prateek Kumar, Shivani Krishna Kapuganti, Vladimir N. Uversky, and Rajanish Giri -- Biology of coronaviruses and predicted origin of SARS-CoV-2 / Giorgio Pal©£, Alberto Reale, Nicolas G. Bazan, Pritam Kumar Panda, Vladimir N. Uversky, Murat Seyran, Alaa A. A. Aljabali, Samendra P. Sherchan, Gajendra Kumar Azad, Wagner Baetas-daCruz, Parise Adadi, Murtaza M. Tambuwala, Bruce D. Uhal, Kazuo Takayama, ©ngel Serrano Aroca, Tarek Mohamed Abd El-Aziz1, Adam M. Brufsky, and Kenneth Lundstrom -- Therapeutic challenges in COVID-19 / Alaa A. A. Aljabal, Murtaza M. Tambuwala, Debmalya Barh, and Kenneth Lundstrom -- Prevention and control strategies for COVID-19 pandemic / Isfendiyar Darbaz, Gizem Morris, and £̀Ø©ơkr©ơ T©ơzmen -- Global focus and interdisciplinary approaches in COVID-19 research and their outcomes / H©ơlya ¿ženol and ¿ž©ơkr©ơ T©ơzmen -- The evolution of COVID-19 diagnostics / Praveen Rai, Ballamoole Krishna Kumar, Deekshit Vijaya Kumar, Prashant Kumar, Anoop Kumar, Shashi Kumar Shetty, and Biswajit Maitia -- Drug repurposing and novel antiviral drugs for COVID-19 management / Shailendra Dwivedi, Aakanksha Rawat, Amit Ranjan, Ruchika Agrawal, Radhieka Misra, Sunil Kumar Gupta, Surekha Kishore and Sanjeev Misra -- Convalescent plasma and antibody therapy in COVID-19 / Didem R♯łfk♯ł, Eymen ©œ. K♯łl♯ł©ʹ and ¿ž©ơkr©ơ T©ơzmen -- Application stem cell and exosome based therapy in COVID-19 / Suleyman Gokhan Kara and Ayla Eker Sariboyaci -- Host and pathogen-specific drug targets in COVID-19 / Bruce D. Uhal, David Connolly, Farzaneh Darbeheshti, Yong-Hui Zheng, Ifeanyichukwu E. Eke. Yutein Chung, and Lobelia Samavati -- Computational biology and bioinformatics in anti-SARS-CoV-2 drug development / Vladimir N. Uversky -- Nanomaterials in COVID-19 drug development / Alaa A A Aljabali, ©ngel Serrano-Aroca, and Murtaza M. Tambuwala -- Vaccine development strategies and the current status of COVID-19 vaccines / Mohsen Akbarian, Kenneth Lundstrom, Elrashdy M. Redwan, and Vladimir N. Uversky -- Clinical trials of COVID-19 therapeutics and vaccines: history, current status, and limitations / Candan Hizel Perry, Havva ©–. K♯łlg©œz, and ¿ž©ơkr©ơ T©ơzmen -- Lessons learned from COVID-19 and their implementations for future pandemics / Mauricio Corredor, Debmalya Barh and Kenneth Lundstrom.
Abstract "The COVID-19 pandemic has affected the entire world in an unprecedented way and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic. Experts of the respective domains provide details on anti-SARS-COV-2 drug strategies, including repurposing drugs used for other indications and development of novel drugs looking at different approaches to target virus entry and replication. COVID-19 vaccine development based on inactivated and attenuated live virus, protein subunit and peptide-based vaccines and utilization of vaccine candidates based on viral vectors, DNA and RNA are presented for both preclinical studies and clinical trials"-- Provided by publisher.
Bibliography noteIncludes bibliographical references and index.
Access restrictionAvailable only to authorized users.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2021049205
ISBN9781032040622 (paperback)
ISBN9781032040639 (hardback)
ISBN(ebook)

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available